Allworth Financial’s Applied Therapeutics APLT Stock Holding History

Allworth Financial’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-250	Closed	–	–	3006
2022 Q3	$0	Hold	250	–	–	﹤0.01%	2641
2022 Q2	$0	Buy	+250	New	+$409	﹤0.01%	2371

Other funds holding APLT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Allworth Financial's APLT Position: Q4 2022 in Review

Allworth Financial sold out of Applied Therapeutics (APLT) in Q4 2022, closing a stake of 250 shares.

Allworth Financial first reported a position in APLT in Q2 2022 and held it in 2 quarters. The position peaked at $0 in Q3 2022. 38 funds tracked by Wall St. Rank hold APLT as of Q4 2022.

Allworth Financial reported no remaining Applied Therapeutics position as of Q4 2022 after selling out during the quarter.
Allworth Financial sold 250 Applied Therapeutics shares in Q4 2022.
Allworth Financial first reported a position in Applied Therapeutics in Q2 2022 and held it in 2 quarters.
Allworth Financial's Applied Therapeutics position peaked at $0 in Q3 2022.
38 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2022.

Based on Allworth Financial's 13F filing for Q4 2022, filed 13 Jan 2023.